Effects of a 10 Component Dietary Supplement on Health and the Quality of Life

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-12

Study Completion Date

2016-08-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open-label field trial evaluates the effects of treatment with a multi-pathway dietary supplement (Stem Cell 100+) that has been commercially available for several years. The objective of the intervention trial is to determine if normal subjects over 35 years of age experience any observable health benefits from the dietary supplement as to their blood pressure, pulse rate, blood cholesterol, lung capacity, stress levels, or self reported changes in markers of overall health and life expectancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19

NCT05629975

Nutrition, Healthy

UNKNOWN NA

Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults

NCT05333315

Overweight and Obesity Inflammation Hypercholesterolemia +1 more

COMPLETED NA

Effects of Coenzyme Q10 Supplementation on Oxidative Stress, Antioxidant Capacity, Inflammatory Responses, Fatigue Elimination, and Exercise Performance in Athletes

NCT03321110

Athlete

COMPLETED NA

Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults

NCT02525224

Skin Health

COMPLETED NA

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

NCT06640465

Wellness Health

ACTIVE_NOT_RECRUITING PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, only dietary restriction has been verified to slow the rate of aging and to promote general health. This trial is designed to see whether a complex supplement (Stem Cell 100+) that targets multiple longevity pathways could also have positive effects on several markers of successful aging and good health. Multipath causes of aging include: stem cell function, telomere loss, chronic stress, inflammation, insulin-like growth factors, autophagy, vascular loss, neural dysfunction, and oxidative stress. The goal of the study was to test the effects of this novel multipath intervention strategy in a clinical trial of healthy people using health markers such as blood pressure, cholesterol status, lung function, stress levels, and self-reported health status. Hundreds of published animal and human clinical studies have been done with each of the individual active ingredients in the formulation, which target many critical causes of aging.

Based on their published animal studies showing extension of life span in a model animal and their laboratory work on adult human stem cells, the investigators believe that Stem Cell 100+ will provide evidence of efficacy in addressing multiple index markers of health and life expectancy outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure HDL Low Stress Lung Function Decreased Quality of Life Energy Supply; Deficiency Concentration Ability Impaired Joint Instability Immune Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Open-label field trial without a placebo.

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stem Cell 100+ Intervention

Subjects take one 650 mg capsule by mouth twice daily for an average of 15 weeks

Group Type EXPERIMENTAL

Stem Cell 100+

Intervention Type DIETARY_SUPPLEMENT

Open-Label 10-Component Dietary Supplement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stem Cell 100+

Open-Label 10-Component Dietary Supplement

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SC100+

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No history of serious cardiovascular, cancer, or neural disease.
* Normal health for age
* Willing to have blood drawn at baseline and after trial
* Willing to submit to evaluation testing of blood pressure, lung testing, stress testing.
* Willing to take online self reported survey of health at end of trial

Exclusion Criteria

* History of metastatic cancer, heart attack, dementia, or other life-threatening disease
* Any subject who is not capable of responding to a self-reported online questionnaire
* Pregnant

Minimum Eligible Age

35 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes